168 related articles for article (PubMed ID: 22184781)
1. Chronic acyclovir-resistant HSV-2 ulcer in an immunosuppressed patient treated with topical cidofovir.
Evans KG; Morrissey KA; Goldstein SC; Vittorio CC; Rook AH; Kim EJ
Arch Dermatol; 2011 Dec; 147(12):1462-3. PubMed ID: 22184781
[No Abstract] [Full Text] [Related]
2. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection.
Sims CR; Thompson K; Chemaly RF; Shpall EJ; Champlin RE; Safdar A
Transpl Infect Dis; 2007 Sep; 9(3):256-9. PubMed ID: 17605730
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient.
Kopp T; Geusau A; Rieger A; Stingl G
Br J Dermatol; 2002 Jul; 147(1):134-8. PubMed ID: 12100196
[TBL] [Abstract][Full Text] [Related]
4. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
Muluneh B; Dean A; Armistead P; Khan T
J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
6. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
7. Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
Ghislanzoni M; Cusini M; Zerboni R; Alessi E
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):887-9. PubMed ID: 16898926
[No Abstract] [Full Text] [Related]
8. Topical cidofovir for viral warts in children.
Fernández-Morano T; del Boz J; González-Carrascosa M; Tortajada B; de Troya M
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1487-9. PubMed ID: 21261749
[No Abstract] [Full Text] [Related]
9. Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient.
Andrei G; Fiten P; Goubau P; van Landuyt H; Gordts B; Selleslag D; De Clercq E; Opdenakker G; Snoeck R
Transpl Infect Dis; 2007 Jun; 9(2):126-31. PubMed ID: 17461998
[TBL] [Abstract][Full Text] [Related]
10. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
11. Cidofovir use in acyclovir-resistant herpes infection.
Martinez CM; Luks-Golger DB
Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391
[TBL] [Abstract][Full Text] [Related]
12. Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
Cha S; Johnston L; Natkunam Y; Brown J
Transpl Infect Dis; 2005; 7(3-4):158-61. PubMed ID: 16390407
[TBL] [Abstract][Full Text] [Related]
13. 1% topical cidofovir used as last alternative to treat viral infections.
Briand S; Milpied B; Navas D; Thomare P; Stalder JF
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429
[No Abstract] [Full Text] [Related]
14. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
[TBL] [Abstract][Full Text] [Related]
16. Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir.
Epstein JB; Gharapetian S; Rejali AR; Zabner R; Lill M; Tzachanis D
Support Care Cancer; 2016 Aug; 24(8):3603-6. PubMed ID: 27165053
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Piret J; Boivin G
Rev Med Virol; 2014 May; 24(3):186-218. PubMed ID: 24604770
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with plasma exchange for disseminated cidofovir-resistant adenovirus disease in a pediatric SCT recipient.
Nishikawa T; Nakashima K; Fukano R; Okamura J; Inagaki J
Bone Marrow Transplant; 2012 Aug; 47(8):1138-9. PubMed ID: 22080967
[No Abstract] [Full Text] [Related]
19. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir.
Osorio S; de la Cámara R; Golbano N; Marti E; Fedele CG; Nieto S; Manzanares R; Fernández-Rañada JM
Bone Marrow Transplant; 2002 Dec; 30(12):963-6. PubMed ID: 12476291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
